Markets · Stocks & ETFs · ADR
Bradespar (OTC: BRAPY)
Brazilian ADR trading on the OTC, priced in US dollars.
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- —
- EPS (TTM)
- —
- Dividend Yield
- —
- 52-Week Range
- —
- Volume
- —
- Previous Close
- —
TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.
About Bradespar
- US Ticker
- BRAPY
- B3 Ticker
- BRAP4
- Exchange
- OTC
- Currency
- USD
- Sector
- —
- Industry
- —
- Headquarters
- —
- Employees
- —
- CEO
- —
- Founded
- —
(Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.)
Financial Results
Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).
Financial Health
Margins, leverage and cash-flow quality derived from Bradespar's income statement, balance sheet and cash flow (absolute figures in USD).
Overall: Financially Strong
- Net Margin
- 88.6%
- ROE
- 10.0%
- Rev Growth (YoY)
- +36.59%
- Net Debt / EBITDA
- —
- Current Ratio
- —
- Interest Coverage
- —
- Free Cash Flow
- —
- Payout Ratio
- —
Income — Margins & Efficiency
| Metric | Last 12MQ2'25 – Q1'26 | Δ | 2025 | Δ | 2024 | Δ | 2023 | Δ | 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170,011,940 | +44.0% | $118,028,743 | -42.2% | $204,165,979 | -49.5% | $404,491,774 | -43.4% | $715,214,397 |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — | — | — | — |
| Net profit | $150,624,904 | +50.8% | $99,885,505 | -48.2% | $192,979,491 | -50.6% | $391,039,339 | -44.6% | $705,384,513 |
| Gross margin | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — |
| EBITDA margin | — | — | — | — | — | — | — | — | — |
| Net margin | 88.6% | +4.0 p.p. | 84.6% | -9.9 p.p. | 94.5% | -2.2 p.p. | 96.7% | -2.0 p.p. | 98.6% |
| Revenue growth (YoY) | 36.6% | +85.3 p.p. | -48.8% | -13.0 p.p. | -35.7% | +12.4 p.p. | -48.1% | — | — |
| Effective tax rate | — | — | — | — | — | — | — | — | — |
| Interest coverage | — | — | — | — | — | — | — | — | — |
Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.
Balance Sheet — Health & Leverage
| Metric | Last 12MQ2'25 – Q1'26 | Δ | 2025 | Δ | 2024 | Δ | 2023 | Δ | 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Net debt | -$48,488,291 | -1786.9% | -$2,569,665 | +94.4% | -$46,213,438 | +8.7% | -$50,643,272 | +34.3% | -$77,129,206 |
| Net Debt / Equity | -0.03× | -1649.0% | -0.00× | +94.5% | -0.03× | -7.3% | -0.03× | +42.5% | -0.05× |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / Equity | 0.00× | -5.0% | 0.00× | +96.2% | 0.00× | +293.8% | 0.00× | -50.3% | 0.00× |
| Current ratio | — | — | — | — | — | — | — | — | — |
| Return on equity (ROE) | 10.0% | +2.8 p.p. | 7.2% | -6.9 p.p. | 14.1% | -10.2 p.p. | 24.2% | -25.6 p.p. | 49.9% |
| Return on assets (ROA) | 9.9% | +3.1 p.p. | 6.8% | -7.0 p.p. | 13.9% | -10.2 p.p. | 24.0% | -22.2 p.p. | 46.2% |
| Book value / share | $3.83 | +7.9% | $3.55 | +1.7% | $3.49 | -15.0% | $4.11 | +14.2% | $3.60 |
Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.
Net Debt & Leverage
Free Cash Flow
Margins
Dividend Payout Ratio
Capex ÷ Revenue
Cash Conversion (operating cash flow ÷ net income)
Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.
Valuation & Dividends
Dividend History
Bradespar has not paid dividends over the past decade.
Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.
Listings
Bradespar trades on 3 exchanges. Prices on this page are the OTC ADR (BRAPY).
| Exchange | Ticker | Currency |
|---|---|---|
| OTCpriced here | BRAPY | USD |
| B3 (São Paulo) | BRAP4 | BRL |
| Latibex (Madrid) | XBRPO | EUR |
Frequently Asked Questions
Where is Bradespar listed?
Bradespar trades on 3 exchanges. The line quoted on this page is OTC in the United States (BRAPY, US dollars). It also trades on B3 (São Paulo) in Brazil (BRAP4, Brazilian reais) and Latibex (Madrid) in Spain (XBRPO, euros).
On how many exchanges does Bradespar trade?
3. OTC — BRAPY (USD) · B3 (São Paulo) — BRAP4 (BRL) · Latibex (Madrid) — XBRPO (EUR). Prices shown on this page are the OTC line, BRAPY.
What is Bradespar's primary listing?
Bradespar's primary listing is on the B3 in Brazil, where the shares trade as BRAP4 in reais — the company's home market. The OTC line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.
What is the difference between BRAPY and BRAP4?
They are the same company and, economically, the same asset. BRAP4 is the original Brazilian share, listed on the B3 and quoted in reais. BRAPY is an American Depositary Receipt over that share, listed on the OTC and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The BRAPY price therefore tracks two things: BRAP4 in reais, and the USD/BRL exchange rate.
How can I buy Bradespar stock in Europe?
Bradespar trades in euros on one European venue: Latibex (Madrid) in Spain (XBRPO). A European broker with access to that market can buy it in EUR, with no currency conversion on your side. The price shown on this page is the OTC line (BRAPY), quoted in US dollars.
How can I buy Bradespar stock in the United States?
Bradespar is listed on the OTC under BRAPY, priced in US dollars. Any US brokerage offering over-the-counter securities can trade it, with no foreign-account paperwork and no currency conversion.
As of Sun, Aug 16, 03:13 BRT · Market closed
Financial data last updated: July 22, 2026






